SPY314.82-0.02 -0.01%
DIA261.41+0.37 0.14%
IXIC10,412.48+21.64 0.21%

HC Wainwright & Co. Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target of $90

HC Wainwright & Co. initiates coverage on Arena Pharmaceuticals (NASDAQ:ARNA) with a Buy rating and announces Price Target of $90.

Benzinga · -
HC Wainwright & Co. initiates coverage on Arena Pharmaceuticals (NASDAQ: ARNA) with a Buy rating and announces Price Target of $90.